I now have all the key information needed for a comprehensive answer. Let me compile everything into a thorough, well-structured response.
Erythropoiesis
Erythropoiesis is the process by which red blood cells (erythrocytes) are produced from hematopoietic stem cells in the bone marrow. Under normal conditions, approximately 1% of circulating erythrocytes is replaced daily - corresponding to about 250 billion cells, with 2.5-3.0 million erythrocytes produced every second.
Sites of Erythropoiesis
| Stage of Life | Site |
|---|
| Yolk sac (primitive) | 0-2 months gestation |
| Liver, spleen | 2nd-7th month gestation |
| Bone marrow (red marrow) | From ~5th month onwards and throughout adult life |
In adults, active red marrow is found in the vertebrae, sternum, ribs, pelvis, proximal femur, and proximal humerus.
Regulation by Erythropoietin (EPO)
The central regulator of erythropoiesis is erythropoietin (EPO), a 30.4-kDa glycoprotein produced primarily in the kidney (peritubular interstitial cells). The oxygen-sensing feedback loop operates as follows:
Figure: EPO stimulation pathway - Kidney senses reduced O₂ delivery → releases EPO → stimulates BFU-E, CFU-E, and pronormoblasts → more circulating red cells
- Hypoxia (from anemia, altitude, cardiopulmonary disease) stimulates HIF-2α in renal interstitial cells
- HIF-2α drives EPO gene transcription
- EPO binds EPO receptors (EPO-R) on erythroid progenitors and promotes their survival, proliferation, and differentiation via the JAK2/STAT5 signaling pathway
- Rising red cell mass corrects tissue oxygenation, completing the negative feedback loop
Progenitor Hierarchy (Pre-Morphological Stages)
These stages are not visible by light microscopy but are defined functionally by colony assays:
HSC → CMP → MEP → BFU-E → CFU-E → Proerythroblast
| Cell | Key Feature |
|---|
| HSC (Hematopoietic Stem Cell) | Self-renewing, pluripotent |
| CMP (Common Myeloid Progenitor) | Gives rise to myeloid lines |
| MEP (Megakaryocyte/Erythrocyte Progenitor) | Bipotent; requires GATA-1 transcription factor for erythroid commitment |
| BFU-E (Burst-Forming Unit - Erythroid) | Large colony-former; EPO-independent initially |
| CFU-E (Colony-Forming Unit - Erythroid) | Small colony-former; highly EPO-dependent |
| Proerythroblast | First morphologically recognizable erythroid cell |
- The full progenitor chain from stem cells is: Stem cell → CFU-GEMM → BFU-EMeg → BFU-E → CFU-E → Pronormoblast
- GATA-1 is the master transcription factor required for terminal erythroid differentiation
Morphologically Recognizable Stages (Maturation Series)
Figure: Normal bone marrow cell stages - erythroid series on the left
1. Proerythroblast (Pronormoblast)
- Size: 12-20 μm (largest erythroid precursor)
- Nucleus: large, spherical, with 1-2 nucleoli
- Cytoplasm: mild basophilia (free ribosomes beginning hemoglobin synthesis)
- Duration: ~24 hours
2. Basophilic Erythroblast
- Size: 10-16 μm (smaller than proerythroblast)
- Nucleus: smaller, progressively more heterochromatic
- Cytoplasm: strong basophilia due to abundant polyribosomes actively synthesizing hemoglobin
- Duration: ~24 hours; undergoes mitosis
3. Polychromatophilic Erythroblast
- Cytoplasm: mixed blue and pink (both ribosomes and accumulating hemoglobin present)
- Nucleus: checkerboard heterochromatin pattern; smaller than previous stage
- Duration: ~30 hours
- Last stage capable of mitosis
4. Orthochromatophilic Erythroblast (Normoblast)
- Cytoplasm: predominantly eosinophilic (large amount of hemoglobin)
- Nucleus: small, compact, pyknotic (dense, dark-staining)
- At this stage, the nucleus is extruded - this is the last nucleated stage
- Cannot undergo further division
5. Reticulocyte (Polychromatophilic Erythrocyte)
- Anucleate
- Still contains residual ribosomes and mRNA - capable of hemoglobin synthesis
- Stains with supravital dyes (e.g., new methylene blue) showing a reticulum of RNA
- Released from bone marrow into blood
- Circulates for 1-2 days; final maturation occurs in the spleen where ribosomes/mRNA are removed
- Normal reticulocyte count: ~0.5-2.5% of RBCs
6. Mature Erythrocyte
- 7.2 μm biconcave disc
- Anucleate, no organelles
- Packed with hemoglobin (~34 g/dL intracellular)
- Lifespan: ~120 days
- Removed by macrophages of spleen, bone marrow, and liver (the mononuclear phagocyte system)
RNA vs. Hemoglobin During Maturation
Figure: As cells mature, RNA (ribosomes) peaks at basophilic erythroblast stage and progressively falls; hemoglobin accumulates from polychromatophilic stage onward and plateaus at the mature erythrocyte
Kinetics Summary
- From basophilic erythroblast → circulation takes approximately 1 week
- Each proerythroblast undergoes 4 mitotic divisions (producing ~16 erythrocytes per progenitor cell)
- Mitosis occurs at: proerythroblast, basophilic erythroblast, and polychromatophilic erythroblast stages only
- Bone marrow is not a storage site for erythrocytes - cells are released as soon as formed
Nutritional Requirements
Three cofactors are essential for effective erythropoiesis:
| Nutrient | Role | Deficiency Effect |
|---|
| Iron | Hemoglobin synthesis (heme component); regulated by HRI kinase sensing heme availability | Microcytic, hypochromic anemia; iron-deficient erythropoiesis |
| Vitamin B12 | DNA synthesis (via methylcobalamin and adenosylcobalamin); thymidine and purine synthesis | Megaloblastic anemia; ineffective erythropoiesis; hypersegmented neutrophils |
| Folate | Single-carbon transfer reactions; pyrimidine and purine synthesis | Megaloblastic anemia; similar to B12 deficiency |
In megaloblastic anemia (B12 or folate deficiency), erythroid progenitors cannot progress through the cell cycle and undergo apoptosis (ineffective erythropoiesis), leading to:
- Reduced reticulocyte count despite erythroid hyperplasia in marrow
- Elevated serum bilirubin and LDH
- Accelerated iron turnover
In iron deficiency, the HRI kinase pathway suppresses globin synthesis and mTORC1 activity, producing microcytic (small) but morphologically normoblastic erythropoiesis.
Iron Recycling
- Each mL of blood contains ~0.5 mg of iron
- The gut absorbs only ~1 mg iron/day (~5-10% of dietary intake)
- The majority of iron for erythropoiesis comes from recycling of iron from aged RBCs via splenic and hepatic macrophages
- Intracellular iron, heme, and globin must be precisely matched - excess of any is toxic
Red Cell Destruction (End of Lifespan)
After ~120 days, senescent erythrocytes are phagocytosed by macrophages of the spleen, bone marrow, and liver:
- Globin → hydrolyzed to amino acids → recycled
- Iron from heme → stored as ferritin/hemosiderin in spleen → recycled to erythropoiesis
- Heme porphyrin ring → partially degraded to bilirubin → bound to albumin → transported to liver → conjugated to bilirubin glucuronide → excreted in bile
Clinical Relevance
| Condition | Mechanism |
|---|
| Anemia of CKD | EPO deficiency (damaged renal interstitium cannot produce EPO); treated with erythropoiesis-stimulating agents (ESAs) |
| Polycythemia vera | Autonomous EPO-independent erythroid proliferation (JAK2 V617F mutation) |
| Thalassemia | Imbalanced globin chain synthesis → precipitation of excess chains → RBC precursor damage → ineffective erythropoiesis → iron overload |
| High-altitude adaptation | Hypoxia → HIF-2α → EPO → increased RBC mass |
| Iron deficiency anemia | Microcytic, hypochromic RBCs; low serum ferritin, high TIBC |
| Megaloblastic anemia | Large oval erythrocytes (macro-ovalocytes), hypersegmented neutrophils |
Sources:
- Histology: A Text and Atlas with Correlated Cell and Molecular Biology, pp. 737-746
- Basic Medical Biochemistry: A Clinical Approach 6e, pp. 1535-1536
- Brenner and Rector's The Kidney, pp. 2465-2470